MedTrace Logo

Prognostic Factors for Survival in Patients With Cholangiocarcinoma

NCT06369480 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2024-04-17

No results posted yet for this study

Summary

The objective of this retrospective study is to determine the survival rates of CCA patients based on different therapeutic approaches. Additionally, we aim to investigate the risk factors associated with poor survival within a cohort of patients treated over a seven-year period across four Danish hospitals. We anticipate that our findings could provide additional evidence for clinical decision-making, improve patient outcomes, and contribute to the knowledge in the field.

Conditions

Interventions

PROCEDURE

Resection/Ablation of tumor

Curative treatment

PROCEDURE

Palliative chemotherapy

Chemotherapeutic medications

PROCEDURE

Neoadjuvant chemotherapy

Chemotherapeutic medications after surgery

PROCEDURE

Stereotatic radiotherapy

Radiotherapy

PROCEDURE

Best supportive care

Symptomatic treatment, non-curative treatment

Sponsors & Collaborators

  • Rigshospitalet, Denmark

    lead OTHER

Principal Investigators

  • Hans-Christian Pommergaard, M.D./Ph.D. · Rigshospitalet, Denmark

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-02-01
Primary Completion
2024-08-31
Completion
2024-08-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06369480 on ClinicalTrials.gov